Details : Also called cholangiocarcinoma, it involves the bile ducts and is often aggressive. 

Research Status : GcMAF (Gc protein-derived macrophage activating factor) is a protein that has been studied for its potential therapeutic effects in various cancers, including bile duct cancer (cholangiocarcinoma). Here are ten possible reasons how GcMAF could help in the case of bile duct cancer: 

1. Immune System Activation : GcMAF can activate macrophages, which are crucial for the immune system to identify and destroy cancer cells.
2. Inhibition of Angiogenesis : It has shown to help inhibit the formation of new blood vessels that tumors need to grow.
3. Reduction of Tumor Growth : Studies suggest that GcMAF slows down or reduce tumor growth by enhancing the body’s natural immune response.
4. Improvement in Quality of Life : Patients receiving GcMAF have reported improvements in overall well-being and energy levels.
5. 5. Synergistic Effects with Other Treatments : GcMAF can be used alongside conventional treatments like chemotherapy, surgery and radiation to enhance their effectiveness.
6. Reduction of Metastasis : Gcmaf is recorded to help prevent the spread of cancer to other parts of the body.
7. Anti-inflammatory Properties : GcMAF has anti-inflammatory effects, which can help reduce cancer-related inflammation.
8. Enhancement of Phagocytosis : It boosts the ability of macrophages to engulf and destroy cancer cells.
9. Normalization of Cell Function : GcMAF can help restore normal cell function and reduce abnormal cell proliferation.
10. Minimal Side Effects : Compared to conventional treatments, GcMAF is reported to have few side effects and no long-lasting side effects.